“Integrated Efficacy of FMX101 4% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Acne Vulgaris: Analyses of Efficacy in Clinically Relevant Subgroups of Patients”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 6, Oct. 2020, p. s89, https://doi.org/10.25251/skin.4.supp.89.